EUVIMEDEUVIMED entdecken
Fallbericht

A Homozygous Variant in NAA60 Is Associated with Primary Familial Brain Calcification

Xinhui Chen iD, Yihua Shi, Feng Fu, Lebo Wang, Hongying Yu, Dehao Yang iD, Xinchen Wang, Chenxin Ying, Haoyu Wang, Zhiru Lin, Haotian Wang iD, Fan Zhang und 15 weitere

Movement Disorders · 2024

DOI: 10.1002/mds.30004 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Movement Disorders, 2024. Verfasst von Xinhui Chen und 26 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Brain Diseases, Calcinosis, N-Terminal Acetyltransferase F. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, Basic Public Welfare Research Program of Zhejiang Province, Science and Technology Program of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Primary familial brain calcification (PFBC) is a monogenic disorder characterized by bilateral calcifications in the brain. The genetic basis remains unknown in over half of the PFBC patients, indicating the existence of additional novel causative genes. NAA60 was a recently reported novel causative gene for PFBC.

Objective

The aim was to identify the probable novel causative gene in an autosomal recessive inherited PFBC family.

Methods

We performed a comprehensive genetic study on a consanguineous Chinese family with 3 siblings diagnosed with PFBC. We evaluated the effect of the variant in a probable novel causative gene on the protein level using Western blot, immunofluorescence, and coimmunoprecipitation. Possible downstream pathogenic mechanisms were further explored in gene knockout (KO) cell lines and animal models.

Results

We identified a PFBC co‐segregated homozygous variant of c.460_461del (p.D154Lfs*113) in NAA60 . Functional assays showed that this variant disrupts NAA60 protein localization to Golgi and accelerated protein degradation. The mutant NAA60 protein alters its interaction with the PFBC‐related proteins PiT2 and XPR1, affecting intracellular phosphate homeostasis. Further mass spectrometry analysis in NAA60 KO cell lines revealed decreased expression of multiple brain calcification–associated proteins, including reduced folate carrier (RFC), a folate metabolism–related protein.

Conclusions

Our study replicated the identification of NAA60 as a novel causative gene for autosomal recessive PFBC, demonstrating our causative variant leads to NAA60 loss of function. The NAA60 loss of function disrupts not only PFBC‐related proteins (eg, PiT2 and XPR1) but also a wide range of other brain calcification–associated membrane protein substrates (eg, RFC), and provided a novel probable pathogenic mechanism for PFBC. © 2024 International Parkinson and Movement Disorder Society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain DiseasesCalcinosisN-Terminal Acetyltransferase FAdultFemaleHumansMaleBrainConsanguinityHomozygotePedigreeSodium-Phosphate Cotransporter Proteins, Type IIIXenotropic and Polytropic Retrovirus Receptor

Stichwörter der Autor:innen

NAA60geneticprimary familial brain calcification

Substanzen

SLC20A2 protein, humanSodium-Phosphate Cotransporter Proteins, Type IIIXenotropic and Polytropic Retrovirus ReceptorXPR1 protein, humanNAA60 protein, humanN-Terminal Acetyltransferase F

Autor:innen und Institutionen

  • Department of Neurology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Department of Neurology, Zhuji People's Hospital of Zhejiang Province, Shaoxing, China.
  • Department of Neurology, Affiliated-Hospital of Shaoxing University, Shaoxing, China.
  • Chu Kochen Honors College, Zhejiang University, Hangzhou, China.
  • Department of Neurology, Wenzhou Central Hospital, Wenzhou, China.
  • Department of Neurology and Institute of Neurology of First Affiliated Hospital, Institute of Neuroscience, and Fujian Key Laboratory of Molecular Neurology, Fujian Medical University, Fuzhou, China.

ORCID-Profile: Xinhui Chen, Dehao Yang, Haotian Wang, Xiaosheng Zheng, Wei Luo

Förderung

  • Fundamental Research Funds for the Central Universities
  • Basic Public Welfare Research Program of Zhejiang Province
  • Science and Technology Program of Zhejiang Province
  • National Natural Science Foundation of China
  • Public Projects of Zhejiang Province
  • Natural Science Foundation of Zhejiang Province

Zitieren

APA

Chen, X., Shi, Y., Fu, F., Wang, L., Yu, H., Yang, D., Wang, X., Ying, C., Wang, H., Lin, Z., Wang, H., Zhang, F., Zheng, X., Guo, Y., Wang, Y., Zeng, Y., Zhao, M., Chen, Y., Li, J., …, & Luo, W. (2024). A Homozygous Variant in NAA60 Is Associated with Primary Familial Brain Calcification. Movement Disorders. https://doi.org/10.1002/mds.30004

Vancouver

Chen X, Shi Y, Fu F, Wang L, Yu H, Yang D, et al. A Homozygous Variant in NAA60 Is Associated with Primary Familial Brain Calcification. Movement Disorders. 2024. doi:10.1002/mds.30004

BibTeX
@article{Chen2024,
  author = {Chen, Xinhui and Shi, Yihua and Fu, Feng and Wang, Lebo and Yu, Hongying and Yang, Dehao and Wang, Xinchen and Ying, Chenxin and Wang, Haoyu and Lin, Zhiru and Wang, Haotian and Zhang, Fan and Zheng, Xiaosheng and Guo, Yuru and Wang, Yaoting and Zeng, YiHeng and Zhao, Miao and Chen, Yiling and Li, Jiaxiang and Xia, Haibin and Chen, Jiawen and Wang, Bo and Wu, Sheng and Xie, Fei and Feng, Jianhua and Cen, Zhidong and Luo, Wei},
  title = {A Homozygous Variant in NAA60 Is Associated with Primary Familial Brain Calcification},
  journal = {Movement Disorders},
  year = {2024},
  doi = {10.1002/mds.30004}
}
Kostenlos starten →